News

Blueberries Medical Corp.
01.11.2019

Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

TORONTO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with the Van Uden International Center for Alternative Medicine (“Van Uden”) and the Juan N.

16.10.2019

‘Los médicos no están bien entrenados sobre el cannabis’: Jahan Marcu

Marcu, experto en la industria, habló con EL TIEMPO sobre los aspectos que se deben regular.

28.09.2019

Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

TORONTO, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp.

24.09.2019

Blueberries Medical y la Sociedad Colombiana de Pediatría lo invitan al primer seminario de cannabis medicinal en Bogotá

El evento se llevará a cabo el 11 de octubre de 2019 en Bogotá con el fin de educar a los pediatras, residentes pediátricos, médicos generales, especialistas en medicina alternativa, psiquiatras y otros profesionales de la salud sobre las aplicaciones y los beneficios del cannabis medicinal.

24.09.2019

Blueberries Medical and The Colombian Society of Pediatrics Invites you to the First Medicinal Cannabis Seminar in Bogota

Events

The event will be held on October 11, 2019 in Bogota and has been designed to educate pediatricians, pediatric residents, general practitioners, alternative medicine specialists, psychiatrists and other health professionals on the applications and benefits of medicinal cannabis.

18.09.2019

Blueberries Medical and The Colombian Society of Pediatrics Partner to Host Medicinal Cannabis Seminar in Bogota

TORONTO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp.

12.09.2019

Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee

TORONTO, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the formation of its medical & scientific committee to support management in the development of leading-edge formulations as well as its ongoing commercial and educational initiatives.

30.08.2019

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

TORONTO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed its over-subscribed, non-brokered private placement (the “Offering”) of units (the “Units”) at a price of C$0.25 per Unit for total gross proceeds of C$3,457,500.

Subscribe to News